Mumbai: ABH Healthcare Limited, which operates multi-speciality healthcare services under the Anil Baghi Hospital brand, will launch its ₹34.98 crore initial public offering (IPO) on August 24, 2026.
The IPO will remain open until August 27, while the shares are tentatively scheduled to list on the NSE SME platform on September 1.
Grey Market Premium Shows Strong Interest
Ahead of the IPO opening, ABH Healthcare shares are reportedly commanding a grey market premium (GMP) of ₹27-₹30 per share.
Against the upper price band of ₹102, this translates into an indicative premium of around 26.5%-29.4%. However, GMP is unofficial and can change sharply before listing.
Price Band And Investment
ABH Healthcare has fixed the IPO price band at ₹96-₹102 per share. The fresh issue comprises 34,29,600 equity shares with a face value of ₹10 each.
The lot size is 1,200 shares. Retail investors are required to apply for at least two lots, or 2,400 shares, involving an investment of ₹2.45 lakh at the upper price band.
The issue includes 1,72,800 shares reserved for the market maker, while the net public issue comprises 32,56,800 shares.
Where Will IPO Money Go?
The company plans to use ₹17 crore from the proceeds to repay or prepay certain borrowings.
Another ₹5 crore will be used to meet working capital requirements. The remaining proceeds will support unidentified acquisitions and general corporate purposes.
Financial Performance Improves
ABH Healthcare’s consolidated revenue increased from ₹41.38 crore in FY24 to ₹52.51 crore in FY26.
During the same period, EBITDA more than doubled from ₹6.89 crore to ₹14.72 crore, while profit after tax jumped from ₹1.66 crore to ₹5.64 crore.
Its EBITDA margin improved from 16.66% to 28.03%, while FY26 return on equity stood at 39.07%.
The company currently operates a 150-bed hospital offering services across 25 medical specialities.